The chemokine system is now recognized as a key element in cancer-related inflammation because it can affect tumor progression acting on tumor-stroma and also directly on tumor cells. Chemokines are produced by both tumor cells and the tumor microenvironment and modulate not only leukocyte infiltration and angiogenesis but also senescence, cell survival and metastasis. Here, we review available information in preclinical and clinical settings that suggest that the chemokine system represents a valuable target for the development of innovative therapeutic strategies.
Targeting Chemokines in Cancer / R. Bonecchi, B. Savino, A. Mantovani, M. Locati. - In: CURRENT IMMUNOLOGY REVIEW. - ISSN 1573-3955. - 8:2(2012), pp. 161-169.
Titolo: | Targeting Chemokines in Cancer |
Autori: | BONECCHI, RAFFAELLA (Primo) SAVINO, BENEDETTA (Secondo) MANTOVANI, ALBERTO (Penultimo) LOCATI, MASSIMO (Ultimo) |
Parole Chiave: | Cancer; Chemokine; Chemokine receptor; Inflammation |
Settore Scientifico Disciplinare: | Settore MED/04 - Patologia Generale |
Data di pubblicazione: | 2012 |
Rivista: | |
Tipologia: | Article (author) |
Digital Object Identifier (DOI): | http://dx.doi.org/10.2174/157339512800099648 |
Appare nelle tipologie: | 01 - Articolo su periodico |